Diabetes Drug Metformin Combats Breast Cancer Stem Cells

In the latest advancement, treatment for breast cancer might be the drug Metformin that until now was used during diabetes. Metformin is already obtainable in many pharmacies broadly under the branding Glucophage and Fortamet. Mounting proofs are suggestive of the fact that those diabetics consuming metformin are less prone to getting cancer and having comparatively better results if they did develop cancer as compared to those who did not take the drug.

Currently, Harvard scientist Kevin Struhl along with his associates discovered that metformin had the potential to destroy breast cancer stem cells believed to be the offenders responsible for proliferation and relapse of breast cancer.

Struhl during a news gathering organised for the announcement of the findings stated that, in mice that carried human breast cancers, the drug metformin was seen to make chemotherapy significantly effectual. Those mice that underwent treatment of the potent combo of metformin and chemotherapy were free of cancer for a period of four months as compared to those mice that underwent treatment with solely the drug.

Struhl further mentioned that while his latest study explores the effects of metformin on breast cancer, the drug could be additionally effective in other cancer types. Metformin was seen to target stubborn cancer stem cells that could not be treated by standard chemotherapy. Cancer stem cells are known to be highly resistant and nastier than normal cancer cells.

Struhl said that the mass of cells present inside a tumor are those cancer cells that grow but get destroyed during chemotherapy. However, there are additionally a tiny populace of cancer stem cells that are more apt at independently forming tumors and are highly resistant to chemotherapy than cancer cells. Despite standard chemotherapy, they continue to survive, effectively regenerating the tumor, leading to the disease relapsing.

Struhl states that Metformin was previously identified as safe and only requires to be established effectual in the human version of the clinical trials.

The other positive aspects about the findings were that Metformin and chemotherapy had an amazing synergy with each other and due to this combined effectuality Metformin could be administered with lower dosages of chemotherapy which is quite ideal due to the noxious nature of chemotherapy. Metformin in low dosages could be regarded as an ideal means of averting cancer even prior to the person having any cancer.

The scientists are hopeful that by the use of the Metformin drug one can continue to lower the levels of the innately stubborn, chemotherapy-resistant, latent cancer stem cells.

Popularity: 4% [?]